Published in NIDA Res Monogr on January 01, 1991
Analytic complexities associated with group therapy in substance abuse treatment research: problems, recommendations, and future directions. Exp Clin Psychopharmacol (2006) 1.44
Addiction treatment-related employment barriers: the impact of methadone maintenance. J Subst Abuse Treat (2012) 0.98
Organizational Barriers to Adopting an Alcohol Screening and Brief Intervention in Community-Based Mental Health Organizations. Best Pract Ment Health (2012) 0.92
Developing an evidence-based, multimedia group counseling curriculum toolkit. J Subst Abuse Treat (2012) 0.80
Temporal variation in facilitator and client behavior during group motivational interviewing sessions. Psychol Addict Behav (2015) 0.80
Organizational correlates of service availability in outpatient substance abuse treatment programs. J Behav Health Serv Res (2011) 0.77
The RoadMAP Relapse Prevention Group Counseling Toolkit™: counselor adherence and competence outcomes. J Subst Abuse Treat (2013) 0.75
Analysis of Hox gene expression in the chick limb bud. Development (1996) 3.47
Variations in methadone treatment practices. Results from a national study. JAMA (1992) 2.83
Sonic hedgehog is an endodermal signal inducing Bmp-4 and Hox genes during induction and regionalization of the chick hindgut. Development (1995) 2.25
Organizational correlates of access to primary care and mental health services in drug abuse treatment units. J Subst Abuse Treat (1999) 2.06
Medical and psychosocial services in drug abuse treatment: do stronger linkages promote client utilization? Health Serv Res (2000) 1.99
An organizational analysis of service patterns in outpatient drug abuse treatment units. J Subst Abuse (1995) 1.67
Increasing access and providing social services to improve drug abuse treatment for women with children. Addiction (2000) 1.63
An institutional analysis of HIV prevention efforts by the nation's outpatient drug abuse treatment units. J Health Soc Behav (1999) 1.62
Depletion of O6-alkylguanine-DNA alkyltransferase correlates with potentiation of temozolomide and CCNU toxicity in human tumour cells. Br J Cancer (1993) 1.60
Hospital bloodborne pathogens programs: program characteristics and blood and body fluid exposure rates. Infect Control Hosp Epidemiol (2001) 1.56
On-site primary care and mental health services in outpatient drug abuse treatment units. J Behav Health Serv Res (1999) 1.53
Morphogenesis of the turtle shell: the development of a novel structure in tetrapod evolution. Evol Dev (2001) 1.47
Nurse experience and education: effect on quality of care. J Nurs Adm (2001) 1.47
The expression of full length Gp91-phox protein is associated with reduced amphotropic retroviral production. Haematologica (2000) 1.40
CD34+AC133+ cells isolated from cord blood are highly enriched in long-term culture-initiating cells, NOD/SCID-repopulating cells and dendritic cell progenitors. Stem Cells (1998) 1.40
Secretion of 72 kDa type IV collagenase/gelatinase by cultured human lipocytes. Analysis of gene expression, protein synthesis and proteinase activity. Biochem J (1992) 1.35
Alkylpurine-DNA-N-glycosylase knockout mice show increased susceptibility to induction of mutations by methyl methanesulfonate. Mol Cell Biol (1998) 1.21
Levels of the DNA repair enzyme human apurinic/apyrimidinic endonuclease (APE1, APEX, Ref-1) are associated with the intrinsic radiosensitivity of cervical cancers. Br J Cancer (1998) 1.15
Ownership and performance of outpatient substance abuse treatment centers. Am J Public Health (1992) 1.12
Linkage to medical services in the Drug Abuse Treatment Outcome Study. Med Care (2001) 1.07
Assembly of trunk and limb blood vessels involves extensive migration and vasculogenesis of somite-derived angioblasts. Dev Biol (2001) 1.05
Inactivation of O6-alkylguanine-DNA alkyltransferase. 1. Novel O6-(hetarylmethyl)guanines having basic rings in the side chain. J Med Chem (1998) 1.03
A life-cycle model of organizational federations: the case of hospitals. Acad Manage Rev (1987) 1.02
Identification of the cross-link between human O6-methylguanine-DNA methyltransferase and chloroethylnitrosourea-treated DNA. Cancer Res (1992) 1.00
Isolation and cDNA cloning of a rat O6-alkylguanine-DNA-alkyltransferase gene, molecular analysis of expression in rat liver. Carcinogenesis (1991) 0.99
Immunohistological examination of the inter- and intracellular distribution of O6-alkylguanine DNA-alkyltransferase in human liver and melanoma. Br J Cancer (1992) 0.98
Monitoring adherence to Standard Precautions. Am J Infect Control (2001) 0.96
Isolation and partial characterization of murine O6-alkylguanine-DNA-alkyltransferase: comparative sequence and structural properties. Mol Carcinog (1992) 0.96
Role of nucleotide excision repair in processing of O4-alkylthymines in human cells. J Biol Chem (1994) 0.95
Hox genes and morphological identity: axial versus lateral patterning in the vertebrate mesoderm. Development (2000) 0.95
Determinants of rural hospital conversion. A model of profound organizational change. Med Care (1996) 0.93
Differential inactivation of mammalian and Escherichia coli O6-alkylguanine-DNA alkyltransferases by O6-benzylguanine. Biochem J (1994) 0.92
The effect of social environment on treatment outcomes in outpatient substance misuse treatment organizations: does race really matter? Subst Use Misuse (1996) 0.91
Evidence for the simultaneous expression of alternatively spliced alkylpurine N-glycosylase transcripts in human tissues and cells. Carcinogenesis (1994) 0.90
O6-benzylguanine potentiates the in vivo toxicity and clastogenicity of temozolomide and BCNU in mouse bone marrow. Blood (1997) 0.89
Selective contracting in managed care: the case of substance abuse treatment. Med Care Res Rev (2001) 0.88
Bacterial and mammalian DNA alkyltransferases sensitize Escherichia coli to the lethal and mutagenic effects of dibromoalkanes. Carcinogenesis (1997) 0.88
Apolipoprotein E genotypes and serum lipid levels in Alzheimer's disease and multi-infarct dementia. Int J Geriatr Psychiatry (1997) 0.88
Determinants of profound organizational change: choice of conversion or closure among rural hospitals. J Health Soc Behav (1996) 0.87
Hospital alliances: cooperative strategy in a competitive environment. Health Care Manage Rev (1990) 0.86
The significant relationship between platelet count and haemorrhagic complications on ECMO. Perfusion (1994) 0.85
Identification of nitrosourea-resistant human rhabdomyosarcomas by in situ immunostaining of O6-methylguanine-DNA methyltransferase. Oncol Res (1993) 0.84
C-terminally truncated human O6-alkylguanine-DNA alkyltransferase retains activity. Biochem J (1992) 0.84
Upregulation of O6-alkylguanine-DNA-alkyltransferase expression and the presence of double minute chromosomes in alkylating agent selected Chinese hamster cells. Carcinogenesis (1992) 0.83
New perspectives for cancer chemotherapy by genetic protection of haematopoietic cells. Expert Rev Mol Med (1999) 0.83
Transient hypereosinophilia in the infant of a mother with hypereosinophilic syndrome. Arch Intern Med (1982) 0.83
Expression of O6-alkylguanine-DNA-alkyltransferase in situ in ovarian and Hodgkin's tumours. Eur J Cancer (1993) 0.83
Enhancing hemopoietic drug resistance: a rationale for reconsidering the clinical use of mitozolomide. Cancer Gene Ther (2000) 0.83
DNA repair deficiency in systemic lupus erythematosus; cause or consequence of disease and implications for management. Lupus (1995) 0.83
Assays to predict the genotoxicity of the chromosomal mutagen etoposide -- focussing on the best assay. Mutat Res (2001) 0.83
The effects of treatment team diversity and size on assessments of team functioning. Hosp Health Serv Adm (1996) 0.82
Chemoprotective gene transfer II: multilineage in vivo protection of haemopoiesis against the effects of an antitumour agent by expression of a mutant human O6-alkylguanine-DNA alkyltransferase. Gene Ther (1998) 0.82
Expression levels of the DNA repair enzyme HAP1 do not correlate with the radiosensitivities of human or HAP1-transfected rat cell lines. Br J Cancer (1999) 0.82
Legal precedents in American law for patient education. Patient Couns Health Educ (1979) 0.82
The emergence of hospital federations: an integration of perspectives from organizational theory. Med Care Rev (1987) 0.82
O6-benzylguanine increases the sensitivity of human primary bone marrow cells to the cytotoxic effects of temozolomide. Exp Hematol (1995) 0.81
Cyclophosphamide decreases O6-alkylguanine-DNA alkyltransferase activity in peripheral lymphocytes of patients undergoing bone marrow transplantation. Br J Cancer (1992) 0.80
The effects of unequal sister chromatid exchange on length of arrays of repeated sequences. J Theor Biol (1993) 0.79
Aggression, deviance, and personality adaptation as antecedents and consequences of alienation and involvement in high school. J Youth Adolesc (1982) 0.79
bcl-2 delay of alkylating agent-induced apoptotic death in a murine hemopoietic stem cell line. Mol Carcinog (1994) 0.78
Porcine collagenase from synovial fibroblasts: cDNA sequence and modulation of expression of RNA in vitro by various cytokines. Matrix (1991) 0.78
Contribution of ogt-encoded alkyltransferase to resistance to chloroethylnitrosoureas in nucleotide excision repair-deficient Escherichia coli. Carcinogenesis (1996) 0.77
Low adolescent self-esteem leads to multiple interpersonal problems: a test a social-adaptation theory. J Pers Soc Psychol (1980) 0.77
Ideologies of care in community residential services: what do caregivers believe? Community Ment Health J (1995) 0.77
The effects of dose, route of administration, drug scheduling and MDR-1 gene transfer on the genotoxicity of etoposide in bone marrow. Leukemia (2000) 0.77
Modulation of O6-alkylating agent induced clastogenicity by enhanced DNA repair capacity of bone marrow cells. Mutat Res (1998) 0.76
Protection of mammalian cells against chloroethylating agent toxicity by an O6-benzylguanine-resistant mutant of human O6-alkylguanine-DNA alkyltransferase. Gene Ther (1996) 0.76
The treatment effectiveness of outpatient substance misuse treatment organizations between court-mandated and voluntary clients. Subst Use Misuse (1996) 0.76
Recombinant adeno-associated virus-mediated expression of O6-alkylguanine-DNA-alkyltransferase protects human epithelial and hematopoietic cells against chloroethylating agent toxicity. Hum Gene Ther (1999) 0.76
Effect of ogt expression on mutation induction by methyl-, ethyl- and propylmethanesulphonate in Escherichia coli K12 strains. Mol Gen Genet (1994) 0.75
Influence of O6-benzylguanine on the anti-tumour activity and normal tissue toxicity of 1,3-bis(2-chloroethyl)-1-nitrosourea and molecular combinations of 5-fluorouracil and 2-chloroethyl-1-nitrosourea in mice. Br J Cancer (1999) 0.75
Atypical molecular profile for joint development in the avian costal joint. Dev Dyn (2010) 0.75
Outcome competencies for organizational behavior and theory. J Health Adm Educ (2001) 0.75
Supervisor ideology and organizational response: HIV/AIDS prevention in outpatient substance abuse treatment units. Adm Soc Work (1997) 0.75
Induction of O6-alkylguanine-DNA-alkyltransferase in the hepatocytes of rats following treatment with 2-acetylaminofluorene. DNA Cell Biol (1997) 0.75
Genotoxicity studies on the azo dye Direct Red 2 using the in vivo mouse bone marrow micronucleus test. Mutat Res (1999) 0.75
School crime and disruption as a function of student-school fit: An empirical assessment. J Youth Adolesc (1980) 0.75
Life after funding: a strategy for survival of a program to prevent substance abuse. J Am Coll Health (1996) 0.75
Role of O6-alkylguanine-DNA alkyltransferase in the resistance of mouse spermatogenic cells to O6-alkylating agents. J Reprod Fertil (2000) 0.75
Gene transfer to augment the therapeutic index of anticancer chemotherapy. Gene Ther (1996) 0.75
The expression of matrix metalloproteinases and their inhibitors by pig synovial cells and their regulation by combinations of cytokines and growth factors. Comp Biochem Physiol B (1993) 0.75
Hospital corporate restructuring and financial performance. Med Care (1993) 0.75
Dollars and sense: the economics of personal health decision-making. Health Policy (1984) 0.75
Limitations of secondary data for strategic marketing in rural areas. Health Serv Manage Res (2000) 0.75
Effect of tetracycline on chondrocyte mitochondria--an explanation of tetracycline-induced defects of mineralized tissues. Biochem Pharmacol (1977) 0.75
Determinants of mental health providers' expectations of patients' improvement. Psychiatr Serv (1997) 0.75
Engineering drug resistance in human cells. Bone Marrow Transplant (2000) 0.75
Nursing care study: modifying behaviour in the institution. Nurs Times (1978) 0.75
The strategies and autonomy of university hospitals in competitive environments. Hosp Health Serv Adm (1990) 0.75
Hospital-physician relations under hospital prepayment. Med Care (1987) 0.75
Feature article: prospective caring--continuing health education of the community. Fam Community Health (1982) 0.75
Analysis of bromide ion in wine by ion selective electrode. J Assoc Off Anal Chem (1976) 0.75
The case for patient education: an update on recent court decisions affecting physicians and hospitals. Patient Couns Health Educ (1981) 0.75
Structural change in academic health centers. Hosp Health Serv Adm (1989) 0.75
Patient understanding: the key to quality patient education. QRB Qual Rev Bull (1981) 0.75
[Will transfer of cytostatic drug resistance genes increase hematopoiesis resistance in the treatment of malignant tumors?]. Cas Lek Cesk (1997) 0.75
Performance quality: combining the best of management practice insight with theoretical inquiry. J Health Adm Educ (1987) 0.75